Regional Network for Mental Health Research in Latin America

描述（由申请人提供）：我们拉丁美洲中心 (HLA) 的首要目标是改善拉丁美洲严重精神障碍患者的状况。我们建议通过集中努力缩小“心理健康差距”来实现这一目标。我们的长期目标是改善严重精神障碍患者的医疗服务，直至其与为患有高度优先的一般健康状况的人提供的最佳医疗服务相当。我们设想建立一个初级保健和二级心理健康服务的综合系统，我们将其称为针对严重精神障碍患者的社区卫生保健 (CHC-SMD)。我们采取多管齐下的方法，针对拉丁美洲城市地区的独特环境量身定制。我们的 5 年资助期目标是启动战略举措，为该地区的 CHC-SMD 取得重大进展，并为在较长时间内持续取得进展建立一个平台。 HLA 汇集了来自拉丁美洲六个城市（智利圣地亚哥；巴西里约热内卢；布宜诺斯艾利斯、科尔多瓦、阿根廷内乌肯；哥伦比亚麦德林）的主要研究人员和利益相关者以及纽约市的研究人员，齐心协力，朝着 CHC-SMD 的共同愿景取得进展。这些组件被设计为具有协同作用，使得整个 HLA 的影响大于其各部分的总和。例如，研究部分建议试点一项区域随机对照试验（RCT）。为了使 HLA 按计划进行全面的区域随机对照试验，能力建设部分将需要培训 HLA 站点的领导者进行随机对照试验并协调区域研究。与此同时，试点随机对照试验将通过提供随机对照试验和区域研究的实践经验来帮助培养这种能力。 我们的总体具体目标是 (a) 部署和评估可以加速 CHC-SMD 进展的任务转移方法； (b) 培训年轻领导人，使其具备在 CHC-SMD 方面不断取得进展所需的能力； (c) 汇集多个利益相关者，为实施和制定 CHC-SMD 做出贡献。

DESCRIPTION (provided by applicant): The overriding objective of our Hub for Latin America (HLA) is to improve the condition of people with severe mental disorders in Latin America. We propose to do so by making a focused contribution to narrowing the "mental health gap". Our long-term goal is to improve health services for people with severe mental disorders until they are equivalent to the best health services offered to people with highly prioritized general health conditions. We envision an integrated system of primary care and secondary mental health services that we refer to as Community Health Care for individuals with Severe Mental Disorders (CHC-SMD). We adopt a multi-pronged approach that is tailored to the distinctive context of the urban areas of Latin America. Our goals for the 5-year grant period are to launch strategic initiatives that will generate significant progress toward CHC-SMD in this region, and to build a platform for ongoing progress over a longer time period. The HLA brings together key researchers and stakeholders from six cities across Latin America (Santiago, Chile; Rio de Janeiro, Brazil; Buenos Aires, Cordoba, Neuquen, Argentina; Medellin, Colombia) with researchers in New York City in a concerted effort to make progress toward a shared vision of CHC-SMD. The Components are designed to be synergistic so that the impact of the whole HLA is greater than the sum of its parts. The Research Component, for example, proposes to pilot a regional randomized controlled trial (RCT). In order for the HLA to proceed as planned to conduct a full scale regional RCT, the Capacity Building Component will need to train leaders at the HLA sites to conduct RCTs and coordinate regional studies. At the same time, the pilot RCT will help generate this capacity by providing practical experience in RCTs and regional studies. Our overall specific aims are (a) to deploy and evaluate task shifting approaches that can accelerate progress toward CHC-SMD; (b) to train young leaders with the capacities required to generate ongoing progress toward CHC-SMD; and (c) to bring together multiple stakeholders to contribute to implementing and shaping CHC-SMD.